| scholarly article | Q13442814 |
| P2093 | author name string | Erik A Ranheim | |
| Paul M Sondel | |||
| Qing-Li Wu | |||
| Alexander L Rakhmilevich | |||
| Ilia N Buhtoiarov | |||
| P2860 | cites work | Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins | Q24300005 |
| Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway | Q28216760 | ||
| The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors | Q28512624 | ||
| CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia | Q33334835 | ||
| Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia | Q34020828 | ||
| Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression | Q34068006 | ||
| Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal | Q36361532 | ||
| Infectious complications of chronic lymphocytic leukemia | Q36449680 | ||
| Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells | Q37378914 | ||
| Immunoregulatory cell dysfunction in chronic B-cell leukemias | Q37997489 | ||
| Endosomal translocation of CpG-oligodeoxynucleotides inhibits DNA-PKcs-dependent IL-10 production in macrophages | Q38294773 | ||
| TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. | Q38329839 | ||
| IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. | Q38346264 | ||
| Fas ligation induces apoptosis of CD40-activated human B lymphocytes | Q39018355 | ||
| L-NAME inhibits tumor cell progression and pulmonary metastasis of r/m HM-SFME-1 cells by decreasing NO from tumor cells and TNF-alpha from macrophages | Q40005831 | ||
| Synergistic activation of macrophages via CD40 and TLR9 results in T cell independent antitumor effects | Q40338312 | ||
| Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40. | Q40372837 | ||
| CD40 ligation activates murine macrophages via an IFN-gamma-dependent mechanism resulting in tumor cell destruction in vitro | Q40425600 | ||
| Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity | Q40628602 | ||
| Role of nitric oxide in tumour progression: lessons from human tumours | Q41051336 | ||
| CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes | Q41740503 | ||
| CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53. | Q41953887 | ||
| Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. | Q42472435 | ||
| Nitric oxide-dependent downregulation of adipocyte UCP-2 expression by tumor necrosis factor-alpha | Q42795889 | ||
| Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells | Q42942217 | ||
| Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis | Q44392036 | ||
| Toll-like receptors stimulate human neutrophil function | Q44493366 | ||
| Inducible nitric oxide synthase inhibitors prolonged the survival of skin xenografts through selective down-regulation of pro-inflammatory cytokine and CC-chemokine expressions. | Q44612917 | ||
| Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. | Q46065498 | ||
| Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma | Q48986235 | ||
| Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors. | Q49094344 | ||
| T cell progenitors emerge earlier than B cell progenitors in the murine fetal liver. | Q51081086 | ||
| Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer. | Q52008378 | ||
| T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibody | Q56904563 | ||
| Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation | Q70538883 | ||
| Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells | Q71000366 | ||
| Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells | Q73386737 | ||
| Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods | Q74166415 | ||
| CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help | Q77402954 | ||
| Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40 | Q77966184 | ||
| Protective role of carnitine in breast cancer via decreasing arginase activity and increasing nitric oxide | Q80773411 | ||
| Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha | Q83984890 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphocyte | Q715347 |
| macrophage | Q184204 | ||
| leukemia | Q29496 | ||
| chronic lymphocytic leukemia | Q1088156 | ||
| P304 | page(s) | 6771-6778 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Tumoricidal effects of activated macrophages in a mouse model of chronic lymphocytic leukemia | |
| P478 | volume | 182 |
| Q39637537 | Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages |
| Q26863784 | Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression |
| Q36825411 | Immunomodulatory effects of interferons in malignancies |
| Q47153253 | Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR. |
| Q34329242 | Macrophages in multiple myeloma: emerging concepts and therapeutic implications |
| Q34822571 | Microglia/macrophages promote glioma progression |
| Q36010202 | RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans |
| Q26773053 | TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia |
| Q43428464 | Th1 cytokines are more effective than Th2 cytokines at licensing anti-tumour functions in CD40-activated human macrophages in vitro |
| Q28751751 | The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo |
| Q36610868 | Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects |
| Q35925252 | Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma |
| Q90749110 | iNOS Interacts with Autophagy Receptor p62 and is Degraded by Autophagy in Macrophages |
Search more.